Janus Henderson Group PLC Xenon Pharmaceuticals Inc. Transaction History

Janus Henderson Group PLC

$187 Billion
Q3 2024

A detailed history of Janus Henderson Group PLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 2,552,392 shares of XENE stock, worth $99.3 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

2,552,392

Previous 1,045,257 144.19%

Holding current value

$99.3 Million

Previous $40.8 Million 146.44%

% of portfolio

0.05%

Previous 0.02%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$36.12 - $43.96 $54.4 Million - $66.3 Million	1,507,135 Added 144.19%	2,552,392 $100 Million
Q2 2024 Aug 14, 2024	BUY	$36.25 - $43.75 $3.76 Million - $4.54 Million	103,688 Added 11.01%	1,045,257 $40.8 Million
Q1 2024 May 15, 2024	SELL	$42.66 - $50.04 $1.04 Million - $1.23 Million	-24,496 Reduced 2.54%	941,569 $40.5 Million
Q4 2023 Feb 14, 2024	BUY	$28.7 - $46.46 $16.8 Million - $27.1 Million	583,760 Added 152.69%	966,065 $44.5 Million
Q3 2023 Nov 14, 2023	BUY	$34.16 - $39.73 $1.88 Million - $2.18 Million	54,961 Added 16.79%	382,305 $13.1 Million
Q2 2023 Aug 14, 2023	BUY	$34.84 - $43.54 $204,824 - $255,971	5,879 Added 1.83%	327,344 $12.6 Million
Q1 2023 May 15, 2023	BUY	$33.46 - $40.35 $993,059 - $1.2 Million	29,679 Added 10.17%	321,465 $11.5 Million
Q4 2022 Feb 14, 2023	BUY	$33.06 - $39.43 $1.92 Million - $2.29 Million	57,952 Added 24.78%	291,786 $11.5 Million
Q3 2022 Nov 14, 2022	SELL	$30.79 - $39.82 $1.32 Million - $1.71 Million	-42,840 Reduced 15.48%	233,834 $8.43 Million
Q2 2022 Aug 15, 2022	BUY	$25.44 - $35.16 $6.78 Million - $9.37 Million	266,393 Added 2591.12%	276,674 $8.41 Million
Q1 2022 May 16, 2022	BUY	$25.09 - $33.13 $257,950 - $340,609	10,281 New	10,281 $315,000

Others Institutions Holding XENE

# of Institutions

212

Shares Held

70.2M

Call Options Held

88.3K

Put Options Held

28.8K

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.42B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Xenon Pharmaceuticals Inc. Transaction History